Objective: Fat embolization to the brain is a potential problem in cardiac surgery, assumed to originate from retransfused pericardial suction blood. Our aim was to measure the fat content in pericardial suction blood and to determine how it can be reduced by simple spontaneous density separation and surface absorption.
B rain damage remains a vexing problem in cardiac surgery. 1 The reported incidence of stroke is about 4 % for coronary artery bypass graft (CABG) procedures. 2 It is suggested that aortic manipulation contributes to stroke, in particular if the ascending aorta is found to be atherosclerotic. However, stroke (type I injury) is rare in comparison with type II injury, which denotes deterioration in intellectual and cognitive functions without signs of focal lesions. 3 Type II injury, here described as diffuse brain damage (DBD), has been reported to occur in more than 50% of patients at discharge after CABG surgery. 3 Although frequent and therefore assumed easy to investigate, DBD is multifactorial and difficult to define. 4 Microembolization of wound-fat particles is a possible DBD mechanism. Fat accumulates on the surface of blood in the pericardial cavity and is retrieved in pericardial suction blood (PSB). With the routine use of cardiopulmonary bypass (CPB), PSB is continuously recycled after passing a screen filter. PSB mixes with systemic blood in the venous reservoir and is expelled into the ascending aorta and brain circulation. This type of embolic process was identified years ago 5 
but later
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neglected until more recent studies reported fat deposits in brain vessels, described as "small capillary and arteriolar dilations" (SCADs). 6 A clear relation between the appearance of SCADs and PSB retransfusion has been described in animal experiments. 7 Further, the in vitro capillary flow properties of PSB plasma have been found to be severely impaired, with fat contamination as a suggested mechanism. 8 It was also demonstrated that SCADs were significantly reduced when PSB was processed by washing with a cell salvage device. 9 The present study aimed to evaluate the dynamics of fat behavior in blood during incubation. A simple and alternative fat-reducing system (FRS), which was tested experimentally and clinically, is proposed from these findings.
Patients and Methods

Patients
The study had approval from the local ethics committee, and patients signed a written consent form. For the clinical part, involving elective first-time CABG procedures, PSB was collected in a single-chamber bag (n ϭ 10) or processed in a specially designed bag (eg, FRS, n ϭ 10). For the experimental part, discarded pericardial fat and postoperative mediastinal blood were collected from patients having routine cardiac surgery (n ϭ 24 for 12 experiments; see Table 1 ).
Surgery, Anesthesia, and CPB
The CPB prime solution contained 1.1 L Ringer acetate, 60 g mannitol, and 160 mmol NaCl. Heparin was added to obtain an activated clotting time exceeding 480 seconds. CPB included an integrated venous/cardiotomy hard-shell reservoir (Affinity NT; Medtronic, Tolochenaz, Switzerland). Cold antegrade crystalloid cardioplegic solution was given (St Thomas Hospital-II), and CPB used moderate hypothermia, acid-base alpha-stat regimen, and flow rate to maintain a venous saturation above 70%. The CABG procedures followed routine surgical guidelines and included use of a side-biting clamp. Anesthesia included fentanyl, midazolam, propofol, pancuronium, and inhaled isoflurane.
Single-chamber Bag Used for Blood Collection
A single-chamber bag was used to measure the volume of PSB and its fat content, as reference to the FRS, and consisted of an empty 2-L infusion bag (No 9315; Fresenius Kabi AB, Uppsala, Sweden). The bag was inserted distal to the pump along the PSB cardiotomy suction line. Air escaped the bag via a vent to the cardiotomy reservoir.
Description of the FRS
The FRS was in principle a soft-shell reservoir built around a ¼-inch tube (Figure 1 ). 10 The FRS had intersecting welds creating two stacked compartments, with a top chamber for blood collection and a bottom chamber mainly for blood storage, both of 750-mL volume capacity. The chambers were separated by a water-lock mechanism. Fat separated from blood during incubation by density and in addition by surface adsorption to the plastic walls. 11, 12 The top fraction of fat-concentrated blood (21.4 mL) was automatically retained by the water-lock at drainage. The reservoir and tubing were of uncoated standard-type polyvinylchloride materials, identical to that of the Polystan SAFE II Softshell Venous Reservoir (Polystan A/S, Denmark/Maquet AG, Germany).
The FRS was identically interpositioned within the PSB suction line as described for the single-chamber bag. Air escaped the FRS by a vent line, which also served as an escape route in the event of blood overfilling. In case of profound bleeding, the FRS worked with through-flow if clamps were released. A minimum 10-minute incubation was allowed in the top and bottom chambers, according to previous findings. 11 At clamp release the PSB entered the cardiotomy reservoir by hydrostatic drainage.
Abbreviations and Acronyms
CABG ϭ coronary artery bypass graft CPB ϭ cardiopulmonary bypass DBD ϭ diffuse brain damage FRS ϭ fat-reducing system PSB ϭ pericardial suction blood SCADs ϭ small capillary and arteriolar dilations Experimental fat/blood refers to patient from whom pericardial fat tissue and mediastinal blood was collected. Experimental group also contained non-coronary artery bypass graft procedures. NYHA, New York Heart Association score (I-II-IIIA-IIIB-IV); CPB, cardiopulmonary bypass.
The PSB suction was managed on the surgeon's request. PSB was here retained, which departed from our normal routine of continuous recycling. Blood from aortic venting was not pooled with PSB. In the single-chamber experiments, PSB was collected in one portion and retransfused before CPB weaning. At this point, a 15-mL blood sample was drawn after thorough mixing of the bag.
Venous return blood was sampled simultaneously. After surgery, the empty bag was saved for further analysis (see below). The FRS experiments had a more complex ambition with a conflict between mixing of blood to receive a representative blood sample and the necessity to allow spontaneous fat separation. Five 15-mL blood samples were collected. The initial sampling was from the top chamber and drawn immediately before its drainage into the bot-tom chamber. This sample was aspirated from the FRS vent port (referred to as "top-chamber input"). The aspiration made the bag collapse, and the sample was a mixture of blood from outside and inside the water-lock. Mixing of blood inside the FRS was not required with this sampling technique. Venous return blood was simultaneously collected (venous control). FRS output blood was sampled just before PSB retransfusion, being subdivided into an initial PSB output and blood assumed to be retained inside the bottom chamber (bottom-chamber "output" and "retained"). In the event of more than one cycle of PSB filling and emptying, blood was collected from the first passage only, with extrapolation for any additional volumes. The FRS was recovered after use, and PSB retained by the water-lock was aspirated ("top chamber retained").
Fat Measurement
Fat was measured metrically. 10 In brief, standard 150-mm Pasteur pipettes were used as centrifugation tubes. The wide end of the pipette was sealed with silicone rubber and left to harden. While held upside down, blood was loaded through the seal using a needle and positioned the same way in a modified swing-out rotor centrifuge (4K15; Sigma Laborzentrifugen GmbH, Osterodeam-Harz, Germany). At 2000g, 10 minutes, and 22°C, fat accumulated in the tapered tip of the pipette, which amplified its volume in relation to its wide barrel with plasma and blood cells. Pipettes (S/N 110601; Tamro MedLab, Mölndal, Sweden) of the same lot number were calibrated for volume-versus-distance and expressed in three linked equations considering the narrow conical tip, cone, and barrel, respectively. The hematocrit value was also recorded.
The measurement of surface-bound fat was designed to avoid previously described artifacts 10 and was here measured by weight before and after detergent washing. A geometrically defined template was used to cut out 8 sheets from the recovered bags, for the FRS subdivided between the top and bottom chambers. The fatcoated surface was hydrophobic to blood, although any such remains were gently absorbed by soft cellulose tissue. The sheets were allowed to dry for 24 hours followed by weighing. Adherent fat was removed by scrubbing in water at 38°C with 0.3% added laboratory detergent (Extra; Rekal AB, Gnesta, Sweden). The sheets were left to redry and were reweighed. The reduction in weight equaled the amount of bound fat, expressed per area. The inside surface of the bags, and for FRS the top and bottom chambers, was geometrically measured to extrapolate the total amount of plastic-bound fat.
Experimental Study: Laboratory Evaluation of the FRS
The FRS fat separation was experimentally simulated by a defined blood/fat mixture. Fat was derived from discarded pericardial tissue, removed to gain access to the left internal thoracic artery. Liquid fat was extracted at 200°C for 10 minutes, which simulated fat melting by electrocautery. 11 Blood was collected from discarded mediastinal drain containers (Affinity NT/CVR; Medtronic, Tolochenaz, Switzerland). Blood was prefiltered through a 200-m screen filter (Mediplast AB, Malmö, Sweden), 10 E/mL heparin added, and 250 mL was mixed with liquid fat to yield 1.25% volume concentration. This concentration was selected to gain maximum resolution, considering the pipette geometry used 
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Appelblad and Engström for fat measurement, as well as in consideration of the measured PSB-fat concentration from the above single-chamber experiments. Blood was allowed to incubate for 10 minutes in each of the top and bottom chambers. All experiments were conducted at 22°C. The analysis tested the difference in fat concentration between the measured input versus output of blood and did not require measurement of fat-to-plastic binding. For reference, the fat content in mediastinal drain blood was measured before being mixed with added fat. Experiments were designed to keep transfer steps of blood to an absolute minimum, a consistent use of materials, and applying reproducible and proper mixing procedures of blood samples. 10
Statistical Methods
Median values and quartiles are given throughout. Nonparametric analyses were used including the Friedman analysis of variance, Wilcoxon signed rank test, Mann-Whitney U test, and Spearman rank correlation.
Results
Patient Demographics and Surgical Data
The patient cohort showed normal characteristics for routine CABG procedures. The subdivision of patients into singlechamber bag or FRS demonstrated no significant differences (not shown). The recorded waste-suction bleeding was 325 mL (maximum 700 mL). None of the patients required allogeneic blood during surgery. The median transfusion requirement during hospitalization was 2 units ( Table 1 ). The patients from whom pericardial fat tissue and postoperative mediastinal blood were collected for experimental purpose included not only those having CABG procedures and showed a somewhat deviant demographic pattern (Table 1) . Table 2 shows PSB-related data subdivided into singlechamber and FRS and demonstrated no group differences in hemoglobin concentration: preoperatively, systemically during surgery, or in PSB. The FRS group contained 1 patient with outlier characteristics (Figure 2 ). This patient had a deviant and substantially higher PSB bleeding of 2.4 L. Three patients had a PSB volume above 1 L. The described outlier patient partly affected the recorded data in Table 2 with respect to PSB characteristics. The recorded PSB fat volume was identical in the two groups. However, there was a near significant (P ϭ .063) higher concentration of fat recorded in the FRS group (Table 2) , which was solely due to a higher amount of plastic-bound fat. With the outlier excluded, this difference diminished (P ϭ .113). The PSB collection time was of the order of 60 minutes ( Table 2 ). In the FRS group, 6 of 10 patients had the top chamber drained into the bottom chamber for storage and the top chamber refilled. However, in all but the described outlier patient was PSB returned in one portion at CPB weaning. There were effects from hemodilution, comparing the minimum systemic hemoglobin concentration versus its preoperative value (P Ͻ .001). When PSB was corrected for hemodilution, the effective PSB bleeding was reduced from 418 mL to 314 mL (P Ͻ .001, Table 2 ).
Clinical PSB Data
PSB Fat Characteristics
The fat volume in PSB was 1.5 mL, which corresponded to a concentration of 0.37% (n ϭ 20). The concentration showed no relationship to PSB volume, which was regardless of the outlier patient ( Figure 2 ). However, there was a positive correlation between the amount of total fat and PSB volume, observed also with the outlier omitted (P ϭ .010). The recorded input PSB fat was the summation of that measured in blood and plastic-bound fat inside the collecting chamber. Plastic-bound fat was measured for the entire single-chamber bag, whereas for the FRS, only considering the top chamber. Plastic-bound fat showed no correlation to 
Fat-reducing Efficacy of FRS in Clinical Study
The behavior of fat inside the FRS thus revealed effects of density separation and plastic binding (Figure 3 ). Bottomchamber blood was reduced in fat by 60% (42/70), as shown by comparing the output fraction of blood with the average of the two input samples from the top chamber (P ϭ .001, Figure 3, a) . This comparison only considered bloodsuspended fat and not plastic binding. Fat reaching the bottom chamber continued to separate by density, which produced a significantly higher concentration of fat in the retained upper portion of blood compared with its lower fraction (P ϭ .017). Control venous blood had no recorded fat (Figure 3, a) . Plastic-bound fat accounted for a significantly smaller portion than that contained in blood (P ϭ .017, Figure 3, b) . Plastic binding mainly occurred in the top chamber compared with that measured in the bottom chamber (P ϭ .005, Figure 3, b) . When both density separation and plastic binding were encountered together, the FRS gave a 73% (69/82) fat reduction. This reduction assumed that the upper layer of PSB in the bottom chamber was retained at drainage. Without this routine the reduction was 66% (59/73), representing a less efficient result (P ϭ .022). Additional fat was eliminated due to the fact that not all PSB, and therefore fat, passed the FRS. The water-lock retained 21.4 mL and with an additional 25 mL retained in the bottom chamber the reduction rate was recalculated to 80% (72/86). The PSB storage also resulted in red cell sedimentation with a concentrating effect (P ϭ .001). The highest hematocrit value was seen for the bottomchamber output blood, a value equal to that of venous blood (P ϭ .445).
Fat-reducing Efficacy of FRS in Experimental Study
Postoperative mediastinal drain blood was mixed with heatextracted liquid pericardial fat. The mediastinal blood had a hematocrit value of 14.9% (12.4/17.6), numerically but not significantly lower than that recorded for input PSB (P ϭ .093). In 5 of 12 patients, minor concentrations of fat were recorded in the mediastinal blood, with a maximum of 0.07%. This endogenous fat was disregarded in the mixture with added pericardial fat aimed to yield 1.25% and did not affect the results. However, this mixture was recorded to contain only 1.00% fat, owing to fat-to-plastic binding inside the mixing container. The FRS efficacy was simply calculated from the measured input versus output fat concentration, not requiring analysis of plastic binding. Bloodsuspended fat was evidently reduced (P Ͻ .001, Figure 4) , with an 83% (71/92) reduction rate encountering the retained volumes of blood in the top and bottom chambers, as described above. The upper blood layer in the bottom cham- ber ("retained") was not significantly higher in fat content versus the output fraction (P ϭ .480).
Discussion
It is obvious that PSB contains fat, assumed to mainly consist of triglycerides. 13 The human body does not have biological mechanisms to rapidly handle nonemulsified fat of this sort. Fat becomes expelled into the ascending aorta and reaches the brain microcirculation within seconds. The present study demonstrated a fat volume of 1.5 mL suspended in about 0.4-L PSB. Although it has not been scientifically demonstrated that fat contributes to DBD, it is tempting to assume such a relationship in view of the presence of SCADs 7 and the found impairment of capillary flow properties of fat-contaminated PSB plasma. 8 Our study demonstrated that fat can be reduced in PSB during incubation by simple density separation and surface adsorption. The suggested FRS had two stacked chambers with an intersecting water-lock. The FRS yielded an 80% fat-reduction rate when evaluated clinically, and with a similar performance under experimental conditions. The FRS worked as clinically intended, patients tolerated the retained volume well, and no allogeneic blood was required during surgery. The ability to visualize PSB bleeding gave feedback to the perfusionist and surgeon, a phenomenon that may promote blood conservation. The FRS had no volume restrictions and fat accumulated during repeated filling.
Washing with a cell salvage device is the gold standard for fat removal in cardiac surgery 9 with a proposed efficacy of 87%. 14 However, an easier method is to discard PSB although this maneuver is counterbalanced by an increased need for allogeneic blood. Blood transfusions are associated with known risks, exemplified by transfusion errors and reactions, transmitted virus, or immunomodulation. 15, 16 An intraoperative blood loss exceeding 0.4 L has been suggested to trigger allogeneic transfusion during CABG pro-cedures 17 and could potentially be affected by discarding PSB. It therefore seems reasonable to suggest that PSB should be separated from direct CPB return and instead be temporarily held to decide strategy for its use, as accomplished by the FRS. The proposed system may also serve as a complement to other fat-reducing devices.
The cell salvage device has obvious benefits but is costly and cumbersome, which may hamper feasibility. An important aspect of the cell salvage device is the removal of inflammatory mediators contained in plasma. 18 On the negative side, there is loss of possibly important plasma components. A simpler alternative is a fat-reducing filter within the PSB suction line. However, such filters have been questioned because of a limited 40% fat removal, partly owing to saturation. 12, 19 Stacked filters may improve the efficacy, as suggested by Kaza and coworkers, 20 with additive effects from the integrated cardiotomy-reservoir filter. Conversely, filters may trigger complement activation in drain blood. 21 It is difficult to compare the results of previous reports owing to their variability in used fat-quantifying methods, exemplified by semiquantitative recordings versus the counting of fat globules only. 14, 20 Our study used a metric centrifugation technique. Of major importance is how blood samples are collected, mixed, and handled, as fat separates fast in blood, and how fat globules disperse or merge during these procedures. 10 Plastic binding must also be considered. 10 The experimental part herein was designed to mimic the clinical situation. Heat-extracted pericardial fat was used to resemble electrocautery melting and mixed with mediastinal drain blood. Our study confirmed that fat adheres to plastic surfaces. This suggests that the cardiotomy reservoir indeed participates in fat reduction. Jewell and coworkers 14 proposed a 45% fat reduction by this mechanism. This phenomenon was here demonstrated by a 24% binding of input fat to plastic walls. A similar percentage was observed experimentally during blood-fat mixing in a plastic container. Thus, with the FRS connected in series with a routine cardiotomy reservoir, a higher fat-reducing efficiency can be anticipated than that actually measured. Recalculated from the study of Jewell and coworkers, 14 it is possible that these combined mechanisms will provide the FRS with a near 90% fat reduction before PSB enters the venous reservoir. Means to further improve the FRS performance may include an increased area for fat binding and use of temperature modulation. 10, 11 This study is limited from not studying the outcome in patients and the possible benefits of fat reduction in terms of DBD. However, such an ambition would require a substantially larger number of observations and is further complicated by the multifactorial nature of DBD. The present study aimed at describing the presence of fat in PSB only, and how fat can be reduced by simple means. The mecha-nism by which some fat escapes the FRS and the characteristics of this particular fat remain to be investigated.
In conclusion, PSB contains fat, although its clinical relevance remains to be elucidated. It is here suggested that PSB should be collected to allow decision making regarding its use. The proposed FRS was meant to provide this feasibly, while at the same time offering an effective fat reduction nearly comparable with that of a cell salvage device.
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